Published in PLoS One on August 03, 2017
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA (2003) 34.83
Antidepressant effects of ketamine in depressed patients. Biol Psychiatry (2000) 10.91
Nitric oxide synthases: structure, function and inhibition. Biochem J (2001) 9.73
The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) (1985) 7.53
The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev (2005) 4.64
Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 4.63
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov (2008) 4.46
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry (2001) 4.33
The economic cost of brain disorders in Europe. Eur J Neurol (2012) 3.53
The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol (1997) 2.67
Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat Med (2010) 2.15
CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron (1998) 2.05
Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol (2013) 1.87
A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry (2006) 1.83
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.78
Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain. Biochem Biophys Res Commun (1990) 1.61
Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc (2012) 1.59
Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. Neuroreport (1994) 1.56
The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev (2005) 1.43
Intra- and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav (2001) 1.31
The Flinders sensitive line rats: a genetic animal model of depression. Neurosci Biobehav Rev (1993) 1.31
Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants. Mol Psychiatry (2003) 1.22
Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections. Dialogues Clin Neurosci (2014) 1.15
Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage (2000) 1.12
Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents. Br J Pharmacol (2009) 1.11
Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats. J Am Assoc Lab Anim Sci (2013) 1.05
Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants? Eur J Pharmacol (1997) 1.04
The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death. J Neurosci (2013) 1.01
Differentiating antidepressants of the future: efficacy and safety. Pharmacol Ther (2006) 1.01
Direct intraventricular delivery of drugs to the rodent central nervous system. J Vis Exp (2013) 1.01
Involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test. Eur Neuropsychopharmacol (2010) 1.00
Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors. Br J Pharmacol (2011) 1.00
The flinders sensitive line rat model of depression--25 years and still producing. Pharmacol Rev (2013) 0.99
Brain damages in ketamine addicts as revealed by magnetic resonance imaging. Front Neuroanat (2013) 0.97
Elevated plasma nitrate levels in depressive states. J Affect Disord (2001) 0.96
Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo. J Neurochem (1996) 0.92
Small-molecule inhibitors at the PSD-95/nNOS interface have antidepressant-like properties in mice. Neuropsychopharmacology (2013) 0.92
Nitric oxide and major depression. Nitric Oxide (2011) 0.90
Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans. Am J Vet Res (2011) 0.85
Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats. Physiol Behav (1999) 0.85
Comparative evaluation of forced swim test and tail suspension test as models of negative symptom of schizophrenia in rodents. ISRN Psychiatry (2012) 0.85
Interaction of nNOS with PSD-95 negatively controls regenerative repair after stroke. J Neurosci (2014) 0.84
Abnormalities in white matter microstructure associated with chronic ketamine use. Neuropsychopharmacology (2013) 0.84
Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics. Neuropharmacology (2015) 0.83
Involvement of serotonin receptor subtypes in the antidepressant-like effect of TRIM in the rat forced swimming test. Pharmacol Biochem Behav (2010) 0.82
The role of the NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of duloxetine in the forced swimming test. Pharmacol Biochem Behav (2012) 0.82
Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice. Pharmacol Biochem Behav (2008) 0.81
Small-molecule inhibitors at the PSD-95/nNOS interface attenuate MPP+-induced neuronal injury through Sirt3 mediated inhibition of mitochondrial dysfunction. Neurochem Int (2014) 0.81
Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors. Behav Brain Res (2016) 0.80
Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions. Sci Rep (2015) 0.78
Nitric oxide involvement in the antidepressant-like effect of ketamine in the Flinders sensitive line rat model of depression. Acta Neuropsychiatr (2014) 0.77
Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test. Biomed Pharmacother (2016) 0.76
Exploring Female Mice Interstrain Differences Relevant for Models of Depression. Front Behav Neurosci (2015) 0.76
Involvement of NMDA receptors and l-arginine/nitric oxide/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test. Brain Res Bull (2016) 0.76
Metabolic investigation on ZL006 for the discovery of a potent prodrug for the treatment of cerebral ischemia. Bioorg Med Chem Lett (2016) 0.76
Nitric Oxide Synthase Inhibitors as Antidepressants. Pharmaceuticals (Basel) (2010) 0.75